Accession Number: | 0001179110-15-006445 |
Date: | 2015-03-29 |
Issuer: | MOMENTA PHARMACEUTICALS INC (MNTA) |
Original Submission Date: |
LEICHER BRUCE
C/O MOMENTA PHARMACEUTICALS, INC.
675 WEST KENDALL STREET
CAMBRIDGE, MA 02142
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2015-03-29 | D | 6,750 | d | $0.00 | 137,862 | direct | ||
COMMON STOCK | 2015-04-16 | M | 30,000 | a | $15.12 | 167,862 | direct | ||
COMMON STOCK | 2015-04-16 | M | 10,000 | a | $15.12 | 177,862 | direct | ||
COMMON STOCK | 2015-04-16 | F | 6,215 | d | $17.08 | 171,647 | direct | ||
COMMON STOCK | 2015-04-16 | S | 30,000 | d | $20.00 | 141,647 | direct | ||
COMMON STOCK | 2015-04-16 | S | 10,000 | d | $20.00 | 131,647 | direct | ||
COMMON STOCK | 2015-04-17 | S | 12,910 | d | $18.05 | 118,737 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 15.12 | 2015-04-16 | deemed execution date | M | 30,000 (a) | 2012-08-19 | 2018-08-19 | common stock 30,000 | $15.12 | 16,452 | direct | |
STOCK OPTION (RIGHT TO BUY) | 15.12 | 2015-04-16 | deemed execution date | M | 10,000 (a) | 2012-08-19 | 2018-08-19 | common stock 10,000 | $15.12 | 43,548 | direct |
ID | footnote |
---|---|
f1 | represents a decrease of 6,750 shares of restricted common stock, $0.0001 par value per share, pursuant to the related restricted stock agreement, as amended, between mr. leicher and the company. the shares were awarded pursuant to the company's 2004 stock incentive plan, as amended. |
f2 | represents the number of shares of restricted common stock returned to the company to meet minimum tax liability requirements, pursuant to the related exercise and restricted stock agreement, as amended, between mr. leicher and the company. the shares were awarded pursuant to the company's 2004 stock incentive plan, as amended. |
f3 | this sale was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on august 5, 2013. |
f4 | this transaction was executed in multiple trades at prices ranging from $18.00 to $18.44. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |